GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
Gold stocks outperform equity market gains
October 06, 2025 / www.canadianminingreport.com
Most major producers rise but TSXV gold mixed
October 06, 2025 / www.canadianminingreport.com
Platinum, palladium, copper gain on green China, supply constraints
September 29, 2025 / www.canadianminingreport.com
Gold stocks continue to soar as markets stumble
September 29, 2025 / www.canadianminingreport.com
Gold stocks again reach new highs
September 22, 2025 / www.canadianminingreport.com